Chimeric Therapeutics LimitedASX: CHM

First patient dosed in Phase 1/2 trial of CHM CDH17

Aug 28, 2024 at 4:18 AM UTC · Issued by Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release.

View Attachment